Please use this identifier to cite or link to this item:
|Title:||Treatment of suspected hyper-reactive malarial splenomegaly (HMS) in pregnancy with mefloquine|
Mara L. Leimanis
Nicholas J. White
Francois H. Nosten
John Radcliffe Hospital
Nuffield Department of Clinical Medicine
Shoklo Malaria Research Unit
|Keywords:||Immunology and Microbiology;Medicine|
|Citation:||American Journal of Tropical Medicine and Hygiene. Vol.90, No.4 (2014), 609-611|
|Abstract:||Malaria infections in pregnancy are associated with adverse outcomes for both mother and child. There are few data on hyper-reactive malarial splenomegaly, an aberrant immunological response to chronic or recurrent malaria in pregnancy. This retrospective assessment reviewed the impact of mefloquine treatment on pregnant women with suspected hyper-reactive malarial splenomegaly in an area of low malaria transmission in the 1990s, showing significant reductions in spleen size and anemia and anti-malarial antibody titers without any notable negative effect on treated women or their newborns. Copyright © 2014 by The American Society of Tropical Medicine and Hygiene.|
|Appears in Collections:||Scopus 2011-2015|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.